These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin. Gomes CM, Abrunhosa AJ, Pauwels EK, Botelho MF. Cancer Biother Radiopharm; 2009 Apr; 24(2):215-27. PubMed ID: 19409044 [Abstract] [Full Text] [Related]
4. [131I]MIBG exports via MRP transporters and inhibition of the MRP transporters improves accumulation of [131I]MIBG in neuroblastoma. Kobayashi M, Mizutani A, Nishi K, Muranaka Y, Nishii R, Shikano N, Nakanishi T, Tamai I, Kleinerman ES, Kawai K. Nucl Med Biol; 2020 Apr; 90-91():49-54. PubMed ID: 33032192 [Abstract] [Full Text] [Related]
5. Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells. Le Jeune N, Perek N, Denoyer D, Dubois F. Cancer Biother Radiopharm; 2005 Jun; 20(3):249-59. PubMed ID: 15989470 [Abstract] [Full Text] [Related]
6. MDR1, MRP1 and LRP expression in patients with untreated acute leukaemia: correlation with 99mTc-MIBI bone marrow scintigraphy. Ak Y, Demirel G, Gülbas Z. Nucl Med Commun; 2007 Jul; 28(7):541-6. PubMed ID: 17538395 [Abstract] [Full Text] [Related]
7. Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function. Kinuya S, Li XF, Yokoyama K, Mori H, Shiba K, Watanabe N, Shuke N, Bunko H, Michigishi T, Tonami N. Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1529-31. PubMed ID: 14579093 [Abstract] [Full Text] [Related]
9. Modulation of the multidrug resistance of glioma by glutathione levels depletion--interaction with Tc-99M-Sestamibi and Tc-99M-Tetrofosmin. Perek N, Koumanov F, Denoyer D, Boudard D, Dubois F. Cancer Biother Radiopharm; 2002 Jun; 17(3):291-302. PubMed ID: 12136521 [Abstract] [Full Text] [Related]
10. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line. Utsunomiya K, Ballinger JR, Piquette-Miller M, Rauth AM, Tang W, Su ZF, Ichise M. Eur J Nucl Med; 2000 Dec; 27(12):1786-92. PubMed ID: 11189941 [Abstract] [Full Text] [Related]
12. Technetium-99m-tetrofosmin would be a substrate for multidrug resistance-associated protein (MRP): comparison between a leukemia cell line with high MRP gene expression and its parental cell line. Li XF, Kinuya S, Yokoyama K, Konishi S, Ma YY, Watanabe N, Shuke N, Bunko H, Michigishi T, Tonami N. Cancer Biother Radiopharm; 2001 Feb; 16(1):17-23. PubMed ID: 11279794 [Abstract] [Full Text] [Related]
16. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study. Kurata S, Ushijima K, Kawahara A, Kaida H, Kawano K, Hirose Y, Kage M, Kamura T, Ishibashi M, Abe T. Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216 [Abstract] [Full Text] [Related]